Rational mixture therapies, new-generation medications, and new therapeutic targets will push treatment for myelofibrosis beyond the novel focal level on the Janus kinase (JAK) inhibition,…
Rational mixture therapies, new-generation medications, and new therapeutic targets will push treatment for myelofibrosis beyond the novel focal level on the Janus kinase (JAK) inhibition,…